Shu Chen, Ph.D., Professor, Neuropathology, was awarded a strategic initiative grant from the Amyotrophic Lateral Sclerosis (ALS) Association, for his project, "Development of Skin Biomarker for Early Diagnosis of ALS."

Chen joined the Department of Pathology in December 2021, the latest addition to our Neuropathology Division, led by C. Ryan Miller, M.D., Ph.D.

ALS is a progressive neurodegenerative disease. This one year, $60,000 award will help advance Chen's research in diagnosing ALS.